(Q57389875)

Pietro Spitali

3

0 references

Magnus Palmblad

Magnus Palmblad

6

0 references

Hanns Lochmüller

Hanns Lochmüller

10

0 references

Volker Straub

9

Volker Straub

0 references

Jan J Verschuuren

Jan Verschuuren

0 references

Annemieke Aartsma-Rus

Annemieke Aartsma-Rus

0 references

Yuri E.M. van der Burgt

Yuri van der Burgt

0 references

Peter A.C. 't Hoen

Peter 't Hoen

0 references

author name string

F. Cynthia Martin

1

0 references

Monika Hiller

2

0 references

Stijn Oonk

4

0 references

Hans Dalebout

5

0 references

Amina Chaouch

7

0 references

Michela Guglieri

8

0 references

André M. Deelder

Proteomics - Clinical Applications

14

0 references

publication date

11 March 2014

0 references

published in

0 references

volume

8

0 references

issue

3-4

0 references

page(s)

269-278

0 references

cites work

Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

On the development of plasma protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Pathophysiology of duchenne muscular dystrophy: current hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Protein sequencing by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Protein digestion: an overview of the available techniques and recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Electron transfer dissociation mass spectrometry in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Comprehensive comparison of collision induced dissociation and electron transfer dissociation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Quantitative mass spectrometry in proteomics: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Using annotated peptide mass spectrum libraries for protein identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Role of spectral counting in quantitative proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Mass spectrometry-based label-free quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

A guided tour of the Trans-Proteomic Pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Scientific workflow management in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Trans-Proteomic Pipeline supports and improves analysis of electron transfer dissociation data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

21 January 2018

The PeptideAtlas project

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Building and searching tandem mass spectral libraries for peptide identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Hexapeptide library as a universal tool for sample preparation in protein glycosylation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Targeting fibrosis in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Aberrant repair and fibrosis development in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Macrophages: master regulators of inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Gelatinase B: a tuner and amplifier of immune functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Anti-tissue remodeling effects of corticosteroids: fluticasone propionate inhibits fibronectin expression in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072

Inhibition of myostatin reverses muscle fibrosis through apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300072